Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists. More patients using albuterol ...

The UK’s largest asthma study using real-world data has confirmed a link between over-reliance on SABA inhalers (short-acting beta-2 bronchodilators, also referred to as rescue inhalers) and an ...

Teva Pharmaceutical Industries Ltd (NYSE: TEVA) announced new study findings based on newly established clinical thresholds on short-acting beta-agonist (SABA) use and real-world usage of ProAir ...

The US Food and Drug Administration (FDA) has approved the short-acting beta-agonist (SABA) albuterol sulfate inhalation powder (ProAir RespiClick, Teva) for the treatment or prevention of ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced new study findings based on newly established clinical thresholds on short-acting beta ...

Please provide your email address to receive an email when new articles are posted on . The meta-analysis included 27 unique randomized controlled trials and 50,496 patients. Combinations improved ...

Please provide your email address to receive an email when new articles are posted on . Patients who used the Reliever Digihaler System had greater odds for better asthma control compared with ...

person holding blue asthma inhaler Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 ...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA),today announced that full results from the CONNECT1 study evaluating the ProAir ® Digihaler ® ...

Results were presented in a late-breaking oral session at the ATS 2022 annual meeting TEL AVIV, Israel & PARSIPPANY, N.J., May 17, 2022--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva ...